LMP1 strain variants: biological and molecular properties. - Wikidata - wikimedia - TriplyDB

LMP1 strain variants: biological and molecular properties.

LMP1 strain variants: biological and molecular properties.

http://www.wikidata.org/entity/Q34717145

about

Identification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagen The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease Epstein-barr virus sequence variation-biology and disease Novel mechanisms of EBV-induced oncogenesis Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population.Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines.High prevalence of the EBER variant EB-8m in endemic nasopharyngeal carcinomas.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.Unique signaling properties of CTAR1 in LMP1-mediated transformation.Atypical Epstein-Barr viral genomic structure in lymphoma tissue and lymphoid cell lines Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes Epstein-Barr virus in oral shedding of children with multiple sclerosis.Immunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience.The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation.Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.Epstein-Barr virus strains and variations: Geographic or disease-specific variants?Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function.Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia.An update on Epstein-Barr virus and nasopharyngeal carcinogenesis.Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay.Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro.Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development.New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma.

P2860

Q24633907-B03E17AB-A121-4D82-AEF5-C3F36DB383FB Q26998401-136F2121-1639-4E13-9E4D-03AAA6BBF583 Q27003183-9758754A-0273-4913-ACD6-749EAE77DF01 Q27006524-B970ADFC-B90F-4CD3-82FF-79FB4CA61BC6 Q27009016-6D44BD84-55E1-4036-A13C-F166BAB19015 Q28731826-C19031C6-0BFC-4C2A-AAB9-A23410E218DA Q33551720-C52D00AF-B577-42AA-82DD-16C08D25DDC0 Q34173615-1D4CC0EC-594C-4509-A590-12952D67B455 Q34271121-11C307BE-CE24-4DED-9C02-6B8724209A34 Q34286259-06D5E613-BA2E-43C4-AC12-9CC69947C90B Q34611577-E5614677-1F1C-4062-B834-8ECB97ABA4C8 Q35363169-D5560C53-AF5D-40C6-A804-6F68714FB85F Q35586536-78E035EA-836B-4EB6-899B-26F77A2C965E Q35597559-7E3C0AFD-15B5-4FA8-893C-8154190AA36F Q35807158-9487A87B-C4E6-4C17-BDAF-2E02C3D05553 Q35861281-0AB1E76E-14AB-4C58-8591-0025AAF788BC Q36098869-69E051FE-34B5-4C14-900F-A768366C62AC Q36847178-BCEDD041-2EFF-40C4-B1FF-74EF3161DA78 Q37021555-1470F59F-017D-4472-AF28-CCE74CBCD90F Q37112849-391C4351-57CE-4BE4-A3FC-6F80F0C258AA Q37251625-BECB4BB7-41CB-4108-9FC1-955BD6D30EA9 Q37299057-84A168CD-922E-4409-8B7C-A363557DE8FB Q37549340-103B03FD-08A5-4266-9FAB-413ADFD1A1BD Q37726624-E39BD0F5-CB68-452A-A67D-639DAEA07D32 Q37728618-362426A0-C844-4F94-953C-912FF3A5B17A Q38427527-65B7CC4C-FBA5-4277-9C25-371924B89645 Q38779524-3F5CE11D-90A7-46BA-88A1-0BBE9E894BF3 Q38861579-6F71063A-32CC-4472-9B9B-1A2B952E4E8B Q38901360-B500349B-7832-4EE5-BF93-38EC8B6ED7D0 Q39246432-82CC2572-32E4-4A01-926C-2DA3423815E6 Q39787510-2BB4DC8D-1E6F-49C9-8D02-8C6FE10100B1 Q40156856-405AA06A-A8F3-48FE-96CB-2D7737C364AB Q41328752-71133AF7-70B0-43CB-8E09-8CA49EEFC5DC Q42271849-6C57905F-491C-4482-89B2-19454EBC3211 Q42935986-998B724B-CB0B-4CF4-820C-F86E0F5BAB19 Q42943070-EC457C30-1AF7-486B-9AED-D52F9B5AC32B Q45288192-972F1992-AAA9-429E-95E1-FB989FEE4C79 Q45361246-3D36EBD5-AC5B-454E-8DB7-18037B762F8B Q47155578-2A9482CF-7A41-466C-B58E-97C5CF2F94E9 Q52347943-6A786240-7BE6-475E-B0FF-2F8708E23342

P2860

LMP1 strain variants: biological and molecular properties.

http://www.wikidata.org/entity/Q34717145

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

LMP1 strain variants: biological and molecular properties.

@ast

LMP1 strain variants: biological and molecular properties.

@en

LMP1 strain variants: biological and molecular properties.

@nl

type

label

LMP1 strain variants: biological and molecular properties.

@ast

LMP1 strain variants: biological and molecular properties.

@en

LMP1 strain variants: biological and molecular properties.

@nl

prefLabel

LMP1 strain variants: biological and molecular properties.

@ast

LMP1 strain variants: biological and molecular properties.

@en

LMP1 strain variants: biological and molecular properties.

@nl

P1433

Q34717145-2014E588-389A-4FD1-B91E-AFA288F0F5FA

P1476

Q34717145-96134A61-4F9C-4214-8A46-D1A9CF37E7FB

P2093

Q34717145-54F2276C-CACD-449B-BA9D-1C3728DE22F3

P2860

Q34717145-00332E1D-EF72-46B8-A478-F3945CEAB976

Q34717145-031EBF80-762E-455E-8BCE-3B471AB8A0E0

Q34717145-04C19F54-A18C-406A-8838-D05A663C12A2

Q34717145-12734E80-FA52-4563-BA97-6540661E6935

Q34717145-13AC8358-2335-4E77-A37F-60D4010F60A0

Q34717145-18D60750-5AD5-46E7-86D9-17155E79FF42

Q34717145-199C789C-5CEE-4249-B5DD-444BD7C72A6E

Q34717145-1A46FD87-BEFB-4995-92D6-CE634E6924DE

Q34717145-1C45F1C2-929A-495B-853F-68180B28117F

Q34717145-1DF9724D-CE70-4D8A-AD83-95C20B23C26D

P304

Q34717145-A66F78A0-F9C6-4C5A-888E-7232D3F22519

P31

Q34717145-583E81C1-D228-4F6D-9152-E9F23357E7B0

P356

Q34717145-1A367F1F-BE68-4C11-A5E9-E59FE7F4EDA4

P407

Q34717145-C4193DEE-AEDA-4C04-B314-BE5F4EA15A3F

P433

Q34717145-AC966EE1-9CDA-429F-864F-A2B942E5F95C

P478

Q34717145-1DBDB909-4DC2-4EEE-B7B5-3A091F2FE2AA

P50

Q34717145-232E10D0-F57F-46F2-871F-F20ED650E29E

P577

Q34717145-85DD7DB2-804D-4753-AC41-55B0A1BEAEEE

P698

Q34717145-FA2AA63A-10C3-4F6E-A74A-790CF2630316

P932

Q34717145-53485EF3-5F4E-4E2E-ADAB-BF07C806332E

P356

P1433

Journal of Virology

P1476

LMP1 strain variants: biological and molecular properties

@en

P2093

Nancy Raab-Traub

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.

Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

beta-catenin signaling and cancer

Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma

Cell adhesion: the molecular basis of tissue architecture and morphogenesis

P304

6458-6468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00135-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Bernardo A Mainou

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16775333

http://www.w3.org/2001/XMLSchema#string

P932

1488979

http://www.w3.org/2001/XMLSchema#string